Clinical trials
Recruiting Small Cell Lung Carcinoma trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 9 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Boehringer Ingelheim | 2 |
| AbbVie | 1 |
| AstraZeneca | 1 |
| BioNTech SE | 1 |
| Bristol-Myers Squibb | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| GlaxoSmithKline | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 17 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Endometrial Neoplasms | 3 |
| Lung Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Medullary | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.